Format

Send to

Choose Destination
J Hepatol. 2015 May;62(5):1204-6. doi: 10.1016/j.jhep.2014.12.025. Epub 2015 Jan 2.

A randomized trial of daclatasvir in combination with asunaprevir and beclabuvir in patients with chronic hepatitis C virus genotype 4 infection.

Author information

1
Southern California Liver Centers, Coronado, CA, USA. Electronic address: thassanein@livercenters.com.
2
Bristol-Myers Squibb, Hopewell, NJ, USA.
3
Medical Associates Research Group, San Diego, CA, USA.
4
Atlanta Gastroenterology Associates, Atlanta, GA, USA.
5
The Texas Liver Institute, University of Texas Health Science Center, San Antonio, TX, USA.
6
Research and Education Inc, San Diego, CA, USA.
7
CRI Lifetree, Salt Lake City, UT, USA.
8
Inova Fairfax Hospital, Center for Liver Diseases, Falls Church, VA, USA.
9
Miami Research Associates, South Miami, FL, USA.
10
Mercy Medical Center, Baltimore, MD, USA.
11
Bristol-Myers Squibb, Princeton, NJ, USA.
12
Bristol-Myers Squibb, Wallingford, CT, USA.
PMID:
25559328
DOI:
10.1016/j.jhep.2014.12.025
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center